Lymphoblastic Leukemia, Acute, Adult

Oncology
0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Cell Therapy
1100%

Competitive Landscape

1 companies ranked by most advanced pipeline stage

I
IQVIANC - Durham
1 program
Out-of-specification obecabtagene autoleucelN/ACell Therapy1 trial
Active Trials
NCT06799221Available

Clinical Trials (1)

NCT06799221IQVIAOut-of-specification obecabtagene autoleucel

Expanded Access Program for OOS Obe-cel

N/AAvailable

Related Jobs in Oncology

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space